Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Seth M Steinberg Jane B Trepel Tristan M Sissung James L. Gulley William Dahut William Douglas Figg, Sr. |
| Publication date | January 18, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |